Therapeutic efficacy of a novel bispyridinium oxime K203 and commonly used oximes (HI-6, obidoxime, trimedoxime, methoxime) in soman-poisoned male rats and mice
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F13%3A43874868" target="_blank" >RIV/60162694:G44__/13:43874868 - isvavai.cz</a>
Result on the web
<a href="http://www.degruyter.com/view/j/jab.2013.11.issue-1/v10136-012-0015-x/v10136-012-0015-x.xml" target="_blank" >http://www.degruyter.com/view/j/jab.2013.11.issue-1/v10136-012-0015-x/v10136-012-0015-x.xml</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2478/v10136-012-0015-x" target="_blank" >10.2478/v10136-012-0015-x</a>
Alternative languages
Result language
angličtina
Original language name
Therapeutic efficacy of a novel bispyridinium oxime K203 and commonly used oximes (HI-6, obidoxime, trimedoxime, methoxime) in soman-poisoned male rats and mice
Original language description
Based on the results, we can conclude that the oxime K203 is not suitable for the replacement of the oxime HI-6 for the antidotal treatment of acute soman poisoning due to its relatively low potency to counteract acute toxicity of soman.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FP - Other medical fields
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Applied Biomedicine - print
ISSN
1214-021X
e-ISSN
—
Volume of the periodical
11
Issue of the periodical within the volume
1
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
7
Pages from-to
"7-13"
UT code for WoS article
000312363000002
EID of the result in the Scopus database
—